Stevanato Group is led by Sergio Stevanato (President) and his sons, Franco and Marco Stevanato (CEO and Vice President).
Stevanato Group is proud of its family heritage. The close ties of the Stevanato family to the business have been fundamental in allowing the company to expand. It has been able to develop naturally while always understanding the ever increasing complexity of doing business. As the Group has grown, a structured and skilled management team has been put in place, with international roots.
Board of Directors
Moreover, Stevanato Group has adopted a corporate governance that sets the rules for the correct management of the Group, by separating ownership from the operating activities. The Group is managed by a Board of Directors that meets at least 4 times per year deciding on exclusively reserved topics. The Board comprises of executive directors, non-executive directors and independent directors.
A Steering Committee has been established in order to define the multi-annual/annual plans that have to be presented to the Board of Directors for approval. It is led by the CEO and it coordinates all the planning and operating activities of the Group. In 2017 two industry experts have joined Stevanato Group’s Advisory Board. Donald E. Morel - former Chairman and Chief Executive Officer of West Pharmaceutical Services, Inc.- and Madhavan Balachandran, former Executive Vice President/Executive Officer of Amgen Inc, are now part of this internal body, supporting the CEO on strategic topics linked to the Group vision. Meeting 3 times a year, the function provides independent advice on business opportunities, product portfolio strategy and geographic growth. The Group has established and follows a set of rules, including the Group’s Values. These are followed by management in order to reach the Group’s objectives, while taking into consideration stakeholders’ interests.